Brenda Maricela Varriano, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head Protective Devices | 1 | 2022 | 114 | 0.750 |
Why?
|
| Bicycling | 1 | 2022 | 177 | 0.730 |
Why?
|
| Post-Concussion Syndrome | 2 | 2018 | 216 | 0.660 |
Why?
|
| Vestibular Diseases | 1 | 2020 | 217 | 0.610 |
Why?
|
| Anti-HIV Agents | 3 | 2023 | 4255 | 0.550 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2019 | 615 | 0.530 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2023 | 1874 | 0.490 |
Why?
|
| Accidental Falls | 1 | 2020 | 1052 | 0.420 |
Why?
|
| Viral Load | 1 | 2019 | 3294 | 0.360 |
Why?
|
| Frontotemporal Dementia | 2 | 2023 | 243 | 0.350 |
Why?
|
| Canada | 3 | 2023 | 2058 | 0.290 |
Why?
|
| HIV Infections | 3 | 2023 | 16710 | 0.260 |
Why?
|
| Cerebrovascular Disorders | 2 | 2023 | 1504 | 0.260 |
Why?
|
| Genes, Duplicate | 1 | 2020 | 33 | 0.190 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 43 | 0.180 |
Why?
|
| Dideoxynucleosides | 1 | 2020 | 121 | 0.180 |
Why?
|
| Genome, Fungal | 1 | 2020 | 204 | 0.170 |
Why?
|
| Gene Duplication | 1 | 2020 | 327 | 0.170 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 253 | 0.160 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 142 | 0.150 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2017 | 47 | 0.150 |
Why?
|
| Attitude | 1 | 2022 | 778 | 0.140 |
Why?
|
| HIV Protease Inhibitors | 1 | 2019 | 430 | 0.140 |
Why?
|
| Postural Balance | 1 | 2020 | 617 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15167 | 0.120 |
Why?
|
| Age of Onset | 1 | 2020 | 3268 | 0.110 |
Why?
|
| Testosterone | 1 | 2023 | 2428 | 0.110 |
Why?
|
| Age Distribution | 1 | 2018 | 2901 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 1883 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 2747 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2791 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6535 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2583 | 0.080 |
Why?
|
| Seizures | 1 | 2020 | 2842 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77457 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 6959 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12354 | 0.060 |
Why?
|
| Young Adult | 2 | 2022 | 56410 | 0.060 |
Why?
|
| Humans | 12 | 2023 | 743521 | 0.060 |
Why?
|
| Prevalence | 1 | 2020 | 15227 | 0.060 |
Why?
|
| Cognition | 1 | 2020 | 6754 | 0.050 |
Why?
|
| Adult | 4 | 2022 | 213870 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7656 | 0.050 |
Why?
|
| Female | 8 | 2023 | 379875 | 0.050 |
Why?
|
| Professional Competence | 1 | 2022 | 448 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 11734 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2023 | 1449 | 0.040 |
Why?
|
| Eye Movement Measurements | 1 | 2017 | 35 | 0.040 |
Why?
|
| Empathy | 1 | 2022 | 471 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2020 | 435 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 1579 | 0.040 |
Why?
|
| Middle Aged | 2 | 2022 | 213185 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 2025 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57739 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 53285 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 85757 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26303 | 0.030 |
Why?
|
| Learning | 1 | 2022 | 1708 | 0.030 |
Why?
|
| Aged | 2 | 2022 | 163137 | 0.030 |
Why?
|
| Male | 3 | 2019 | 349771 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2748 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1692 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 72325 | 0.020 |
Why?
|
| Curriculum | 1 | 2022 | 3602 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 5126 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7871 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10409 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21723 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 20938 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 40911 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29000 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35300 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23346 | 0.010 |
Why?
|
| Child | 1 | 2020 | 77577 | 0.010 |
Why?
|